---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-007399"
form_type: "8-K"
ticker: "GAMG"
cik: "0000055234"
company_name: "Global Asset Management Group, Inc."
filed_at: "2023-10-05T23:59:59+00:00"
generated_at: "2026-06-10T04:21:08.304440+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kenilworth Systems acquires 60% of Regenecell in share exchange; Swank joins board

## Summary
- KENS issued 2M shares to Steven Swank for 600k shares of Regenecell, gaining 60% control.
- Regenecell net loss $45,872 on $31k revenue for June-Sept 2023; auditor notes going concern doubt.
- Pro forma combined net loss $26,724; KENS shareholders' deficit ~$72k post-acquisition.
- Steven Swank, 83, appointed Director and Secretary effective Sept 30, 2023.
- Regenecell provides medical travel consulting; Swank retains 40% minority interest.

## SEC filing metadata
- accession: 0001477932-23-007399
- form_type: 8-K
- ticker: GAMG
- cik: 0000055234
- company_name: Global Asset Management Group, Inc.
- filed_at: 2023-10-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/55234/000147793223007399/0001477932-23-007399-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/55234/000147793223007399/kens_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-007399
- JSON: https://secwatch.observer/filing/0001477932-23-007399.json
- Plain text: https://secwatch.observer/filing/0001477932-23-007399.txt

## Key facts
- Executive change
  Steven Swank was appointed as Director and Secretary at Global Asset Management Group, Inc..
  - Action: appointed
  - Role: Director and Secretary
  source text: On September 30, 2023, Steven Swank was appointed as a Director and Secretary of the Company following the acquisition by the Company of a 60% controlling interest in Regenecell, Inc., a Company of which Mr. Swank was the President and Founder.
  evidence_url: https://www.sec.gov/Archives/edgar/data/55234/000147793223007399/0001477932-23-007399-index.htm
- M&A Transactions
  Global Asset Management Group, Inc. completed an acquisition involving Regenecell, Inc. (closed 2023-09-30).
  - Action: acquisition
  - Counterparty: Regenecell, Inc.
  - Closing: 2023-09-30
  source text: On September 30, 2023, the Company completed a Share Exchange in which it acquired a 60% controlling equity interest in Regenecell, Inc., a Florida corporation which has been newly-formed and is engaged in the business of medical travel consulting and referral services.
  evidence_url: https://www.sec.gov/Archives/edgar/data/55234/000147793223007399/0001477932-23-007399-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.